No significant benefit of moderate-dose vitamin C on severe COVID-19 cases

There is no specific drug for coronavirus disease 2019 (COVID-19). We aimed to investigate the possible clinical efficacy of moderate-dose vitamin C infusion among inpatients with severe COVID-19. Data of 397 adult patients with severe COVID-19 admitted to a designated clinical center of Wuhan Union...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Open medicine (Warsaw, Poland) Poland), 2021-09, Vol.16 (1), p.1403-1414
Hauptverfasser:	Zheng, Shaoping, Chen, Qiaosen, Jiang, Hongbo, Guo, Chunxia, Luo, Jinzhuo, Li, Sumeng, Wang, Hua, Li, Huadong, Zheng, Xin, Weng, Zhihong
Format:	Artikel
Sprache:	eng
Schlagworte:	Coronaviruses COVID-19 General & Internal Medicine Infectious diseases Life Sciences & Biomedicine Medicine, General & Internal SARS-Cov-2 Science & Technology Vitamin C
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!